Cooperation in the life sciences industry and EU competition law in the context of COVID-19

The life sciences industry is facing unprecedented demands due to COVID-19. From front line carers to researchers and scientists, significant efforts are being put towards caring for those suffering from COVID-19 and preventing the spread of the virus. Amidst the fierce competition to develop vaccines and treatments, there may also be the need to collaborate. As companies develop testing kits, trial drugs, manufacture ventilators, and step up medical supply distribution, they may be concerned about whether their collaboration efforts could draw the scrutiny of competition law enforcers.

Read more: Cooperation in the life sciences industry and EU competition law in the context of COVID-19


Download PDF Back To Listing
Loading data